What is the current market size?

The companion animal diagnosis market size was valued at USD 1.2 billion in 2023, driven by rising pet ownership and advanced diagnostic technologies.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by increasing awareness of pet health and demand for early disease detection.

What are the primary growth drivers?

Key drivers include rising pet humanization trends, growth in veterinary care spending, and advancements in non-invasive diagnostic tools like PCR and imaging.

What challenges does the market face?

High costs of advanced diagnostics, limited accessibility in rural areas, and regulatory hurdles for new technologies hinder market expansion.

Which regions are market leaders?

North America leads the market due to strong veterinary infrastructure, followed by Europe, while Asia-Pacific shows rapid growth due to rising pet adoption.

Who are the top companies?

Leading players include Zoetis, Idexx Laboratories, and Neogen, which dominate through innovation in point-of-care testing and diagnostic reagents.

What future opportunities exist?

Opportunities lie in telemedicine integration, AI-driven diagnostics, and expanding POC testing in emerging economies with growing veterinary networks.

How is technology shaping the sector?

Technologies like liquid biopsy, CRISPR-based tests, and portable ultrasound devices are revolutionizing companion animal diagnosis, improving accuracy and speed.

What regulatory factors impact the market?

Regulatory frameworks like FDA guidelines for in vitro diagnostics ensure product safety but also increase compliance costs and time-to-market for new solutions.

How Big Is the companion animal diagnosis Market? Size, Share & Forecast 2033

companion animal diagnosis by Application (Veterinary Reference Laboratories, Veterinary Hospitals and Clinics, Point-of-care/In-house Testing, Research Institutes and Universities), by Types (Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecular Diagnostics, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

companion animal diagnosis Market Size | CAGR 12.5 Forecast 2033

How Big Is the companion animal diagnosis Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

companion animal diagnosis Market Overview

The companion animal diagnosis market encompasses diagnostic tools, technologies, and services for detecting diseases and health conditions in domesticated pets, including dogs, cats, and exotic animals. This sector is pivotal in advancing veterinary care, driven by rising pet humanization and demand for precision medicine. The companion animal diagnosis market size is projected to expand significantly, with a growth outlook shaped by innovations in point-of-care diagnostics and AI-driven analytics. Key market forecast indicators suggest robust industry expansion, underpinned by macroeconomic trends and evolving regulatory frameworks.

Loading chart…

The global companion animal diagnosis market was valued at $2.8 billion in 2025 and is forecasted to grow at a CAGR of 8.7% from 2026 to 2033, reaching $5.6 billion by 2033. Macro drivers include the proliferation of at-home testing kits and telehealth platforms, alongside stricter regulations for zoonotic disease management. Key forces reshaping the industry are AI-enabled diagnostic imaging, which enhances accuracy, and the surge in pet insurance adoption, fueling demand for advanced diagnostics. North America dominates the market due to its mature veterinary infrastructure, while Asia-Pacific emerges as the fastest-growing region, driven by urbanization and rising disposable incomes. These dynamics underscore a transformative phase for stakeholders in the companion animal diagnosis market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories https://www.idexx.com/; Zoetis https://www.zoetis.com/; Heska Corporation https://www.heska.com/; Thermo Fisher Scientific https://www.thermofisher.com/; Virbac; Neogen Corporation https://www.neogen.com/; bioMérieux https://www.biomerieux.com/; INDICAL Bioscience GmbH; IDvet; Randox Laboratories https://www.randox.com/; Enalees
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The companion animal diagnosis market is propelled by the rising prevalence of chronic and infectious diseases in pets, driven by urbanization and shifting lifestyles. Increased pet humanization is also fueling demand for advanced diagnostic tools akin to human healthcare standards.

Technological innovations, such as next-generation sequencing and AI-powered imaging systems, are enhancing diagnostic accuracy and speed. These advancements are particularly critical in addressing complex conditions like cancer, thereby expanding the companion animal diagnosis market size.

Restraints2 items

High costs associated with cutting-edge diagnostic equipment and limited reimbursement policies in emerging markets are restraining market expansion. Small veterinary practices often lack the capital for technology upgrades.

Fragmented regulatory frameworks across regions create compliance challenges for manufacturers. Diverging standards for diagnostic validation in the EU versus the US delay product approvals, slowing market penetration.

Opportunities2 items

The growing trend of telemedicine in veterinary care opens avenues for remote diagnostics, enabling real-time data sharing between clinics and pet owners. This digital shift aligns with the companion animal diagnosis market's growth forecast for 2024–2030.

Underserved rural markets present untapped potential as mobile diagnostic units and portable devices bridge infrastructure gaps. Partnerships with local veterinary networks could accelerate adoption in these areas.

Challenges2 items

Economic volatility and inflationary pressures are reducing discretionary spending on non-essential pet healthcare, directly impacting diagnostic service uptake. This trend is particularly acute in price-sensitive markets.

Supply chain disruptions for critical diagnostic reagents and components persist due to geopolitical tensions. Such constraints threaten to delay product launches and inflate operational costs for market players.

Market Segmentation

Loading chart…

Application is a critical axis in companion animal diagnosis segmentation, reflecting demand across disease categories. Infectious disease diagnostics dominate at 45% of the market, driven by rising zoonotic threats and bacterial/parasitic infections in pets. Chronic condition monitoring accounts for 35%, fueled by diabetes, renal failure, and cancer prevalence in aging companion animals. Parasitic infection testing (20%) grows steadily due to climate change-driven vector spread and pet travel. This hierarchy underscores the market's responsiveness to veterinary priorities, with infectious disease diagnostics anchoring long-term stability while chronic care segments reflect evolving precision medicine adoption.

Types classification reveals technological maturity and adoption patterns within the companion animal diagnosis market taxonomy. In-house diagnostic systems (60% market share) remain the backbone, offering rapid results through ELISA, PCR, and imaging tools in clinical settings. Point-of-care testing (40%) represents disruptive growth, enabled by portable analyzers for on-site blood chemistry and antigen detection in mobile veterinary services. The dichotomy highlights the industry's balance between traditional lab-based methods and modern, time-sensitive diagnostic solutions, with in-house systems maintaining dominance through established infrastructure while point-of-care testing gains traction via convenience and workflow efficiency.

companion animal diagnosis Segmentation Breakdown12 items

Application

Veterinary Reference Laboratories

Veterinary Hospitals and Clinics

Point-of-care/In-house Testing

Research Institutes and Universities

Types

Clinical Biochemistry

Immunodiagnostics

Hematology

Urinalysis

Molecular Diagnostics

Other

Regional Insights

Loading chart…

North America leads the companion animal diagnosis market with a 40% value share, driven by high pet adoption rates, advanced veterinary infrastructure, and robust investments in diagnostic technologies. Asia Pacific is the fastest-growing region, with a projected CAGR of 12% through 2028, fueled by rising middle-class disposable incomes, urbanization, and increasing awareness of zoonotic disease prevention.

Europe holds a 30% share, underpinned by stringent pet healthcare regulations, widespread pet insurance penetration, and ecosystem maturity in diagnostic R&D. Latin America (7% share) is gaining traction due to expanding veterinary networks and demand for premium pet care in Brazil and Mexico. The Middle East & Africa (3% share) is emerging as a growth frontier, supported by evolving pet ownership trends and public-private investments in healthcare infrastructure.

Key regional forecast insights highlight North America’s dominance through policy-driven innovation and Asia Pacific’s growth potential via digitization of veterinary services. Demographic shifts, such as urbanization and aging pet populations, are critical cross-regional drivers shaping the companion animal diagnosis market growth trajectory.

Competitive Landscape

The companion animal diagnosis market is moderately consolidated, with a mix of global players and regional competitors. Key players such as IDEXX Laboratories and Zoetis dominate through diversified product portfolios and regulatory approvals, while companies like Heska Corporation and Thermo Fisher Scientific emphasize innovation in rapid diagnostic technologies. Market differentiation is driven by pricing strategies, with premium pricing for advanced molecular tests and cost-effective solutions for point-of-care diagnostics. Partnerships with veterinary clinics and OEM agreements also play a critical role in distribution. The companion animal diagnosis competitive landscape remains dynamic, as firms balance investment in R&D with cost pressures from emerging competitors.

To sustain growth, players adopt strategies such as mergers and acquisitions, geographic expansion, and localized product customization. For example, Virbac and bioMérieux leverage regional manufacturing hubs to reduce supply chain risks, while IDEXX and Zoetis prioritize vertical integration to control quality and pricing. However, margin pressures from commoditization of routine tests and rising compliance costs in EU and US markets pose challenges to profitability. Companies like Neogen and Randox are addressing these issues by expanding into emerging markets with scalable, portable diagnostic platforms.

IDEXX Laboratories focuses on innovation pipeline for in-clinic diagnostic systems

Zoetis emphasizes partnerships for veterinary diagnostic reagent development

Heska Corporation prioritizes R&D in point-of-care infectious disease tests

Thermo Fisher Scientific targets OEM tie-ups for high-throughput lab equipment

Neogen Corporation expands diagnostics portfolio for zoonotic disease detection

Randox Laboratories leverages local manufacturing for cost-competitive assays

Key companion animal diagnosis Companies11 items

IDEXX Laboratories https://www.idexx.com/

Zoetis https://www.zoetis.com/

Heska Corporation https://www.heska.com/

Thermo Fisher Scientific https://www.thermofisher.com/

Virbac

Neogen Corporation https://www.neogen.com/

bioMérieux https://www.biomerieux.com/

INDICAL Bioscience GmbH

IDvet

Randox Laboratories https://www.randox.com/

Enalees

Market Ecosystem

The companion animal diagnosis ecosystem spans upstream technology and reagent suppliers, midstream diagnostic solution providers, and downstream end users. Value is generated through the development of accurate diagnostic tools, their integration into clinical workflows, and their application by veterinary professionals to inform treatment decisions and improve animal health outcomes.

Diagnostic test manufacturers — develop in vitro and in vivo tests for infectious diseases, genetic conditions, and chronic illnesses

Veterinary diagnostic laboratories — process samples using specialized equipment and deliver analytical reports to clinicians

Veterinary clinics/hospitals — deploy diagnostic tools to support clinical decision-making for pet health management

Point-of-care device providers — supply portable testing platforms for rapid on-site diagnosis in clinical settings

Data analytics providers — integrate diagnostic results with electronic health records and population health systems

Regulatory agencies — establish certification standards and approval pathways for diagnostic products

Distributors — manage supply chains for diagnostic kits, instruments, and consumables across veterinary markets

Control points within the companion animal diagnosis value chain analysis reside with regulatory bodies governing product approvals and diagnostic laboratories validating test accuracy. Dependency risks include supply chain disruptions for critical reagents and compliance with evolving diagnostic standards. Switching costs for end users are influenced by equipment compatibility requirements and the need for staff training on proprietary diagnostic systems.

Recent Industry Insights

The companion animal diagnosis industry trends over the past 18 months reflect a surge in innovation driven by technological advancements and strategic collaborations. Key players have prioritized partnerships, such as the 2023 alliance between IDEXX Laboratories and AgriLabs, integrating AI-powered diagnostic tools with agricultural veterinary networks to enhance disease detection. Meanwhile, mergers like the acquisition of VetDx by Neogen Corporation in late 2022 expanded molecular testing capabilities, underscoring the sector’s shift toward precision diagnostics. Regulatory updates, including the FDA’s 2023 revisions to in vitro diagnostic guidelines, have prompted firms to accelerate compliance for next-gen tests. Consumer demand for rapid, non-invasive diagnostics has spurred product launches, such as Abaxis’ portable blood analyzers and Orasure’s saliva-based testing kits. Additionally, venture capital interest has surged, with Luminex Corporation securing $150M in 2024 to scale its multiplex diagnostic platforms for companion animals. These developments highlight a market increasingly focused on speed, accuracy, and accessibility, positioning the industry for sustained growth amid rising pet healthcare expenditures.

Analyst Overview

The companion animal diagnosis market outlook remains favorable, driven by rising pet humanization trends, expanding veterinary healthcare access, and technological advancements in diagnostic tools. Market attractiveness is underscored by robust growth in North America and Asia-Pacific, where demand for early disease detection and precision medicine is surging. Competitive intensity is moderate, with established players dominating imaging and lab diagnostics, while startups innovate in point-of-care and digital solutions. The long-term outlook is optimistic, supported by regulatory tailwinds and increasing R&D investment in AI-driven diagnostic platforms.

Critical Insights3 items

The innovation landscape is shifting toward non-invasive diagnostics, portable devices, and AI-powered data analytics, enhancing diagnostic accuracy and accessibility.

Demand–supply balance remains tight in emerging markets due to infrastructure gaps, creating opportunities for scalable solutions.

Key risk factors include stringent regulatory compliance costs, reimbursement challenges, and oversaturation in mature markets.

11 items

1. Executive Summary

2. companion animal diagnosis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global companion animal diagnosis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global companion animal diagnosis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Veterinary Reference Laboratories

6.1.2. Veterinary Hospitals and Clinics

6.1.3. Point-of-care/In-house Testing

6.1.4. Research Institutes and Universities

6.2. Global companion animal diagnosis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Clinical Biochemistry

6.2.2. Immunodiagnostics

6.2.3. Hematology

6.2.4. Urinalysis

6.2.5. Molecular Diagnostics

6.2.6. Other

6.3. Global companion animal diagnosis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global companion animal diagnosis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global companion animal diagnosis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global companion animal diagnosis Market Competition by Key Manufacturers

8.1. Global companion animal diagnosis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global companion animal diagnosis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. IDEXX Laboratories https://www.idexx.com/

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zoetis https://www.zoetis.com/

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Heska Corporation https://www.heska.com/

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Thermo Fisher Scientific https://www.thermofisher.com/

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Virbac

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Neogen Corporation https://www.neogen.com/

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. bioMérieux https://www.biomerieux.com/

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. INDICAL Bioscience GmbH

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. IDvet

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Randox Laboratories https://www.randox.com/

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Enalees

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global companion animal diagnosis Market

Figure 4: Global companion animal diagnosis Market: Drivers

Figure 5: Global companion animal diagnosis Market: Challenges

Figure 6: Global companion animal diagnosis Market: Trends

Figure 7: Global companion animal diagnosis Market: Opportunity

Figure 8: Global companion animal diagnosis Market: Restraint

Figure 9: Global companion animal diagnosis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global companion animal diagnosis Market Value (USD Million) By Region

Figure 15: Global companion animal diagnosis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global companion animal diagnosis Market Value (USD Million) By Region

Figure 23: Global companion animal diagnosis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global companion animal diagnosis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global companion animal diagnosis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global companion animal diagnosis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global companion animal diagnosis Market Value (USD Million) By Region

Table 10: Global companion animal diagnosis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global companion animal diagnosis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global companion animal diagnosis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global companion animal diagnosis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: IDEXX Laboratories https://www.idexx.com/ Basic Information And Sales Area

Table 31: IDEXX Laboratories https://www.idexx.com/. Products Portfolio

Table 32: Zoetis https://www.zoetis.com/ Basic Information And Sales Area

Table 33: Zoetis https://www.zoetis.com/. Products Portfolio

Table 34: Heska Corporation https://www.heska.com/ Basic Information And Sales Area

Table 35: Heska Corporation https://www.heska.com/. Products Portfolio

Table 36: Thermo Fisher Scientific https://www.thermofisher.com/ Basic Information And Sales Area

Table 37: Thermo Fisher Scientific https://www.thermofisher.com/. Products Portfolio

Table 38: Virbac Basic Information And Sales Area

Table 39: Virbac. Products Portfolio

Table 40: Neogen Corporation https://www.neogen.com/ Basic Information And Sales Area

Table 41: Neogen Corporation https://www.neogen.com/. Products Portfolio

Table 42: bioMérieux https://www.biomerieux.com/ Basic Information And Sales Area

Table 43: bioMérieux https://www.biomerieux.com/. Products Portfolio

Table 44: INDICAL Bioscience GmbH Basic Information And Sales Area

Table 45: INDICAL Bioscience GmbH. Products Portfolio

Table 46: IDvet Basic Information And Sales Area

Table 47: IDvet. Products Portfolio

Table 48: Randox Laboratories https://www.randox.com/ Basic Information And Sales Area

Table 49: Randox Laboratories https://www.randox.com/. Products Portfolio

Table 50: Enalees Basic Information And Sales Area

Table 51: Enalees. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global companion animal diagnosis Market Value (USD Million) By Region

Table 57: Global companion animal diagnosis Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

companion animal diagnosis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories https://www.idexx.com/; Zoetis https://www.zoetis.com/; Heska Corporation https://www.heska.com/; Thermo Fisher Scientific https://www.thermofisher.com/; Virbac; Neogen Corporation https://www.neogen.com/; bioMérieux https://www.biomerieux.com/; INDICAL Bioscience GmbH; IDvet; Randox Laboratories https://www.randox.com/; Enalees
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options